Table 2.
Mediators involved in regulation of CD163 receptor.
| Mediator | Upregulation | Downregulation | References |
|---|---|---|---|
| IL-6 | + | − | Buechler et al. (2000) |
| IL-10 | + | − | Buechler et al. (2000) |
| Sulahian et al. (2000) | |||
| Weaver et al. 2007 | |||
| Patton et al. (2009) | |||
| M-CSF | + | − | Ritter et al. (1999) |
| Hb–Hp complexes | + | − | Ugocsai et al. (2006) |
| Dexamethasone | + | − | Ritter et al. (1999) |
| TNF-α | − | + | Buechler et al. (2000) |
| IFN-γ | − | + | Buechler et al. (2000) |
| Weaver et al. (2007) | |||
| TGF-β | − | + | Pioli et al. (2004) |
| GM-CSF+IL-4 | − | + | Ritter et al. (1999) |
| Lipopolysaccharide | − | + | Buechler et al. (2000) |
| Patton et al. (2009) | |||
| 12-O-tetradecanoylphorbol-13-acetate | − | + | Patton et al. (2009) |
IL, interleukin; M-CSF, macrophage colony-stimulating factor; HB–Hp, haemoglobin–haptoglobin; TNF, tumour necrosis factor; IFN, interferon; TGF, transforming growth factor; GM-CSF, granulocyte macrophage colony-stimulating factor.